Gotowa bibliografia na temat „MiR-3192-5p”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „MiR-3192-5p”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "MiR-3192-5p"
You, Qi, Yuan Yao, Jinyu Wu, Congcong Cheng, Yunxiu Li i Haitao Yuan. "YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis". Biomedicine & Pharmacotherapy 129 (wrzesień 2020): 110339. http://dx.doi.org/10.1016/j.biopha.2020.110339.
Pełny tekst źródłaYou, Qi, Yuan Yao, Jinyu Wu, Congcong Cheng, Yunxiu Li i Haitao Yuan. "Retraction notice to "YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis"". Biomedicine & Pharmacotherapy 141 (wrzesień 2021): 111986. http://dx.doi.org/10.1016/j.biopha.2021.111986.
Pełny tekst źródłaMcLaughlin, Tracey, Ingela Schnittger, Anna Nagy, Elizabeth Zanley, Yue Xu, Yanqiu Song, Koen Nieman i in. "Relationship Between Coronary Atheroma, Epicardial Adipose Tissue Inflammation, and Adipocyte Differentiation Across the Human Myocardial Bridge". Journal of the American Heart Association 10, nr 22 (16.11.2021). http://dx.doi.org/10.1161/jaha.121.021003.
Pełny tekst źródłaHAN LEE, WAI, BENJAMIN NELSON, APRIL M. TEAGUE, KEVIN R. SHORT i JEANIE B. TRYGGESTAD. "1174-P: Circulating MicroRNA in Youth with Type 1 Diabetes in Response to a Meal Challenge". Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1174-p.
Pełny tekst źródłaRozprawy doktorskie na temat "MiR-3192-5p"
Brochen, Célia. "Caractérisation des cibles de miARNs sensibilisateurs à l'action de la chimiothérapie en vue de la proposition de nouvelles stratégies thérapeutiques dans les cancers de l'ovaire (SensimiRs)". Electronic Thesis or Diss., Normandie, 2024. http://www.theses.fr/2024NORMC401.
Pełny tekst źródłaAlthough the majority of ovarian cancer patients initially respond to platinum-based chemotherapy, most of them relapse and develop chemoresistance, leading to poor 5-year survival. In this context, it is important to understand the molecular mechanisms involved in chemoresistance in order to develop new therapeutic approaches. In this context, a functional screening of a miRNA library identified several microRNAs (miRNAs) that sensitize two chemoresistant ovarian cancer lines (IGROV1-R10 and SKOV3) to the action of cisplatin, including miR-3192-5p, which induces massive cell death by apoptosis and has never been previously studied. The chemosensitizing effect of this miRNA was then validated on a third chemoresistant ovarian cancer line (OAW42-R). Using an approach combining bioinformatics and functional study, we observed that miR-3192-5p modulates the expression of several proteins involved in DNA damage response and repair mechanisms. Among these targets, we have demonstrated that the ERCC1 protein is a key determinant of the chemosensitizing effect of miR-3192-5p in the IGROV1-R10 and OAW42-R ovarian cancer lines. Preliminary results show that sensitization of SKOV3 cells to cisplatin action may be related to inhibition of CHEK1, whose expression is decreased in response to miR-3192-5p. In summary, this work has enabled us to identify new miRNAs involved in chemoresistance in ovarian cancers, and to characterize more precisely the role of miR-3192-5p and certain targets involved in its chemosensitizing action, opening the way to the proposal of new therapeutic strategies to improve the management of these cancers